Showing results (561-570 of 569) with videos related to
Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 569 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectorsTanja D de Gruijl, Sylvia A Luykx-de Bakker, Bryan W Tillman, et al.The Lancet. Oncology|May 23, 2008
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trialByeong-Ho Park, Taeho Hwang, Ta-Chiang Liu, et al.Plos One|July 23, 2013
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiationJelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer CentreM T Huizing, G Giaccone, L J van Warmerdam, et al.BMC Cancer|May 17, 2018
Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.BMC Cancer|March 1, 2020
Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.Journal for Immunotherapy of Cancer|June 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener studyKarlijn de Joode, Harry J Groen, Michel van den Heuvel, et al.Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.Pageof 57